PHIO Archived Articles
Phio Pharmaceuticals (PHIO): Pioneering Immune-Oncology Therapeutics Through Revolutionary INTASYL Technology
Published on November 30, 2024
Phio Pharmaceuticals Corp. (NASDAQ:PHIO): Immuno-Oncology Innovator Navigating Challenges, Poised for Potential
Published on September 24, 2024